A powerful patient case ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Treating the gut can resolve chronic MCAS & Histamine Intolerance

This patient came to us after years of symptoms that looked like classic MCAS. But despite aggressive treatment, nothing was improving.

Breath testing came back positive for two different types of overgrowth: SIBO Bacterial overgrowth An overgrowth of bacteria in the small intestine. Responds to rifaximin. IMO Methanogen overgrowth A different class of microorganism (archaea) that doesn't respond to the same treatments. Often missed without breath testing.

When he added rifaximin to a broader treatment plan, his symptoms improved dramatically. For the first time in years, he was close to symptom-free. We also have a clear next step: repeat rifaximin, this time with neomycin added to directly target the methanogens that rifaximin alone couldn't clear.

For unresponsive MCAS, the gut is worth looking at, especially when there are digestive symptoms alongside the mast cell picture.

Treating the gut can resolve chronic MCAS & Histamine Intolerance

This patient came to us after years of symptoms that looked like classic MCAS. But despite aggressive treatment, nothing was improving.

Breath testing came back positive for two different types of overgrowth: SIBO Bacterial overgrowth An overgrowth of bacteria in the small intestine. Responds to rifaximin. IMO Methanogen overgrowth A different class of microorganism (archaea) that doesn't respond to the same treatments. Often missed without breath testing.

When he added rifaximin to a broader treatment plan, his symptoms improved dramatically. For the first time in years, he was close to symptom-free. We also have a clear next step: repeat rifaximin, this time with neomycin added to directly target the methanogens that rifaximin alone couldn't clear.

For unresponsive MCAS, the gut is worth looking at, especially when there are digestive symptoms alongside the mast cell picture.

View in Your Browser

No longer want to receive these emails?
Manage Preferences or Unsubscribe
The Ruscio Institute | 11016 Quivira Rd Unit #702 Overland Park, KS 66210